CryoPort, Inc. CYRX Liabilities of discontinued operations (Note 2)

Liabilities of discontinued operations (Note 2) at other companies

AzentaAZTA

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$47.8M+16.5%

Gross profit$21.9M+17.6%

Operating income-$9.6M-33.6%

Net income-$10.5M+12.0%

EPS (diluted)-$0.25+10.7%

Balance sheet

See full

Cash & equivalents$272.9M+656%

Total debt$230.7M+293%

Total equity$495.0M+24.1%

Total assets$763.6M+9.1%

Cash flow

See full

Operating cash flow$3.7M+186%

CapEx$10.0M+215%

Free cash flow-$6.2M+16.8%

Valuation

See full

Market cap$800.39M+151%

Enterprise value$758.23M+122%

P/E10.6×—

P/S4.4×+2.4×

Profitability

See full

Gross margin47.2%+1.6pp

Operating margin-21.4%-8.8pp

Net margin39.2%+22.1pp

FCF margin-13%-3.6pp

Returns & leverage

See full

Return on equity14.5%+8.6pp

Debt / equity0.5×+0.3×

Current ratio2.1×-3.5×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent.

The official record: CryoPort, Inc.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CryoPort, Inc.'s liabilities of discontinued operations (note 2).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CryoPort, Inc.'s liabilities of discontinued operations (note 2)?: CryoPort, Inc. (CYRX) reported liabilities of discontinued operations (note 2) of $7.8M in Q4 2024.